We are analyzing https://link.springer.com/article/10.1007/s10549-018-4834-7.

Title:
The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome | Breast Cancer Research and Treatment
Description:
Purpose The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. Methods PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. Results PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). Conclusion CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

cancer, breast, article, pubmed, google, scholar, pdl, tils, inflammatory, ibc, cas, cells, central, lymphocytes, prognostic, expression, survival, patients, res, tumorinfiltrating, outcome, research, study, httpsdoiorgs, clin, medicine, ariaspulido, tumor, response, death, improved, chaher, bcss, dfs, triplenegative, access, programmed, chemotherapy, oncol, center, usa, supplementary, material, privacy, cookies, content, analysis, ciminomathews, immune, treat,

Topics {✒️}

cd20+tils/pd-l1+tils status anti-pd-l1 antibody mpdl3280a pd-l1 + tumor-infiltrating lymphocytes month download article/chapter tumour-infiltrating lymphocytes cd20+tils/pd-l1+tils triple-negative breast cancer prognostic b-cell signatures anti-pd-1/pd-l1 pd-l1+ immune cells pd-l1+ tumor cells long-term clinical benefit independent prognostic factor large population-based study methods pd-l1 breast cancer-specific survival kaplan-meier survival estimates improved patient outcome oncology meets immunology full article pdf longer disease-free survival related subjects pd-l1 expression anti–pd-1 antibody pd-l1+ tils tumor–infiltrating lymphocytes tumor-infiltrating lymphocytes inflammatory breast cancer stage iii inflammatory immunogenic cell death privacy choices/manage cookies cell-activating immunotherapies article arias-pulido human breast cancer patient outcome multiplexed quantitative analysis triple-negative subtype-specific breast antitumor immune responses ctneobc pooled analysis kaplan–meier curves check access instant access increased tils open-label disease-free survival iridium cancer net end results program end results database geyer ce jr

Questions {❓}

Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobagyi GN (2007) Trends for Inflammatory Breast Cancer: Is Survival Improving?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
         description:The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
         datePublished:2018-06-01T00:00:00Z
         dateModified:2018-06-01T00:00:00Z
         pageStart:273
         pageEnd:282
         sameAs:https://doi.org/10.1007/s10549-018-4834-7
         keywords:
            PD-L1
            CD20
            Immuno-oncology
            Inflammatory breast cancer
            Triple-negative
            Patient outcome
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig3_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:171
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:H. Arias-Pulido
               url:http://orcid.org/0000-0003-4941-1110
               affiliation:
                     name:Geisel School of Medicine at Dartmouth
                     address:
                        name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:A. Cimino-Mathews
               affiliation:
                     name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                     address:
                        name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                        type:PostalAddress
                     type:Organization
                     name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                     address:
                        name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Chaher
               affiliation:
                     name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
                     address:
                        name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Qualls
               affiliation:
                     name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                     address:
                        name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Joste
               affiliation:
                     name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                     address:
                        name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Colpaert
               affiliation:
                     name:Iridium Cancer Net
                     address:
                        name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. D. Marotti
               affiliation:
                     name:Geisel School of Medicine at Dartmouth
                     address:
                        name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Foisey
               affiliation:
                     name:Geisel School of Medicine at Dartmouth
                     address:
                        name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. R. Prossnitz
               affiliation:
                     name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                     address:
                        name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. A. Emens
               affiliation:
                     name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                     address:
                        name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Fiering
               affiliation:
                     name:Geisel School of Medicine at Dartmouth
                     address:
                        name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome
      description:The purpose of the study was to evaluate protein expression of PD-L1 and CD20 as prognostic biomarkers of patient outcome in inflammatory breast cancer (IBC) samples. PD-L1 and CD20 protein expression was measured by immunohistochemistry in 221 pretreatment IBC biopsies. PD-L1 was assessed in tumor cells (PD-L1+ tumor cells) and tumor stromal infiltrating lymphocytes (PD-L1+ TILs); CD20 was scored in tumor-infiltrating B cells. Kaplan–Meier curves and Cox proportional hazard models were used for survival analysis. PD-L1+ tumor cells, PD-L1+ TILs, and CD20+ TILs were found in 8%, 66%, and 62% of IBC, respectively. PD-L1+ tumor cells strongly correlated with high TILs, pathological complete response (pCR), CD20+ TILs, but marginally with breast cancer-specific survival (BCSS, P = 0.057). PD-L1+ TILs strongly correlated with high TILs, CD20+ TILs, and longer disease-free survival (DFS) in all IBC and in triple-negative (TN) IBC (P < 0.035). IBC and TN IBC patients with tumors containing both CD20+ TILs and PD-L1+ TILs (CD20+TILs/PD-L1+TILs) showed longer DFS and improved BCSS (P < 0.002) than patients lacking both, or those with either CD20+ TILs or PD-L1+ TILs alone. In multivariate analyses, CD20+TILs/PD-L1+TILs status was an independent prognostic factor for DFS in IBC (hazard ratio (HR): 0.53, 95% CI 0.37–0.77) and TN IBC (HR: 0.39 95% CI 0.17–0.88), and for BCSS in IBC (HR: 0.60 95% CI 0.43–0.85) and TN IBC (HR: 0.38 95% CI 0.17–0.83). CD20+TILs/PD-L1+TILs status represents an independent favorable prognostic factor in IBC and TN IBC, suggesting a critical role for B cells in antitumor immune responses. Anti-PD-1/PD-L1 and B cell-activating immunotherapies should be explored in these settings.
      datePublished:2018-06-01T00:00:00Z
      dateModified:2018-06-01T00:00:00Z
      pageStart:273
      pageEnd:282
      sameAs:https://doi.org/10.1007/s10549-018-4834-7
      keywords:
         PD-L1
         CD20
         Immuno-oncology
         Inflammatory breast cancer
         Triple-negative
         Patient outcome
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4834-7/MediaObjects/10549_2018_4834_Fig3_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:171
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:H. Arias-Pulido
            url:http://orcid.org/0000-0003-4941-1110
            affiliation:
                  name:Geisel School of Medicine at Dartmouth
                  address:
                     name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:A. Cimino-Mathews
            affiliation:
                  name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                  address:
                     name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                     type:PostalAddress
                  type:Organization
                  name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                  address:
                     name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Chaher
            affiliation:
                  name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
                  address:
                     name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Qualls
            affiliation:
                  name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                  address:
                     name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Joste
            affiliation:
                  name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                  address:
                     name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Colpaert
            affiliation:
                  name:Iridium Cancer Net
                  address:
                     name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. D. Marotti
            affiliation:
                  name:Geisel School of Medicine at Dartmouth
                  address:
                     name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Foisey
            affiliation:
                  name:Geisel School of Medicine at Dartmouth
                  address:
                     name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. R. Prossnitz
            affiliation:
                  name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
                  address:
                     name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. A. Emens
            affiliation:
                  name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
                  address:
                     name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Fiering
            affiliation:
                  name:Geisel School of Medicine at Dartmouth
                  address:
                     name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:171
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Geisel School of Medicine at Dartmouth
      address:
         name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
         type:PostalAddress
      name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
      address:
         name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
         type:PostalAddress
      name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
      address:
         name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
         type:PostalAddress
      name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
      address:
         name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
         type:PostalAddress
      name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
      address:
         name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
         type:PostalAddress
      name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
      address:
         name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
         type:PostalAddress
      name:Iridium Cancer Net
      address:
         name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
         type:PostalAddress
      name:Geisel School of Medicine at Dartmouth
      address:
         name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
         type:PostalAddress
      name:Geisel School of Medicine at Dartmouth
      address:
         name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
         type:PostalAddress
      name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
      address:
         name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
         type:PostalAddress
      name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
      address:
         name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
         type:PostalAddress
      name:Geisel School of Medicine at Dartmouth
      address:
         name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:H. Arias-Pulido
      url:http://orcid.org/0000-0003-4941-1110
      affiliation:
            name:Geisel School of Medicine at Dartmouth
            address:
               name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:A. Cimino-Mathews
      affiliation:
            name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
            address:
               name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
               type:PostalAddress
            type:Organization
            name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
            address:
               name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:N. Chaher
      affiliation:
            name:Centre Pierre et Marie Curie et Faculté de Médecine d’Alger
            address:
               name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
               type:PostalAddress
            type:Organization
      name:C. Qualls
      affiliation:
            name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
            address:
               name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
               type:PostalAddress
            type:Organization
      name:N. Joste
      affiliation:
            name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
            address:
               name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
               type:PostalAddress
            type:Organization
      name:C. Colpaert
      affiliation:
            name:Iridium Cancer Net
            address:
               name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:J. D. Marotti
      affiliation:
            name:Geisel School of Medicine at Dartmouth
            address:
               name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
               type:PostalAddress
            type:Organization
      name:M. Foisey
      affiliation:
            name:Geisel School of Medicine at Dartmouth
            address:
               name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
               type:PostalAddress
            type:Organization
      name:E. R. Prossnitz
      affiliation:
            name:The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center
            address:
               name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
               type:PostalAddress
            type:Organization
      name:L. A. Emens
      affiliation:
            name:The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy
            address:
               name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
               type:PostalAddress
            type:Organization
      name:S. Fiering
      affiliation:
            name:Geisel School of Medicine at Dartmouth
            address:
               name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
      name:Departments of Pathology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
      name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
      name:Department of Pathology, Centre Pierre et Marie Curie et Faculté de Médecine d’Alger, Algiers, Algeria
      name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
      name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
      name:Department of Pathology, Oncology Centre, GZA Hospitals, Iridium Cancer Net, Antwerp, Belgium
      name:Pathology and Laboratory Medicine, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
      name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
      name:Departments of Pathology, Mathematics and Statistics, and Internal Medicine, The University of New Mexico Comprehensive Cancer Center, and Health Sciences Center, Albuquerque, USA
      name:Departments of Oncology, The Johns Hopkins University School of Medicine and Bloomberg–Kimmel Institute for Immunotherapy, Baltimore, USA
      name:Departments of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(178)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.62s.

LINK . SPRINGER . COM {}